<strong><em>Ginkgo Biloba</em> Leaves and Depression</strong>

Abstract

ZHANG Hai-hong, WANG Shu.Ginkgo BilobaLeaves and Depression[J]. Acta Neuropharmacologica, 2013, 3(5): 43-49.

[1] 边爱红. 浅谈抑郁症 [J]. 内蒙古中医药, 2011, 30(2):135.

[2] 李林艳, 徐建. 抑郁症治疗进展 [J]. 河南中医, 2012, 32(12): 1720-1722.

[3] 罗和春, 钱瑞琴. 中西医结合治疗抑郁症新进展 [J]. 中国中西医结合杂志, 2009, 29(3): 197-198.

[4] Nancy Diazgranados, Lobna Ibrahim, Nancy E Brutsche, et al. A randomized addon trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression [J]. Arch Gen Psychiatry, 2010, 67(8): 793-802.

[5] Marije aan het Rot, Katherine A Collins, James W Murrough, et al. Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression [J]. Biol Psychiatry, 2010, 67(2): 139-145.

[6] Sungho Maeng, Carlos A Zarate, Jing Du , et al. Cellular mechanisms underlying the antidepressant effects of ketamine: role of α-amino-3-hydroxy-5-methyliso- xazole-4-propionic acid receptors [J]. Biological Psychiatry, 2008, 63(4): 349-352.

[7] Sheldom H Preskorn, Bryan Baker, Sheela Kolluri, et al. An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101, 606, in patients with treatment-refractory mmajor depressive disorder [J]. J Clin Psychopharmacol, 2008, 28(6): 631-637.

[8] Shashank M Dravid, Kevin Erreger, Hong-jie Yuan, et al. Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block [J]. J Physiol, 2007, 581 (1): 107-128.

[9] 胡永东, 于欣, 杨甫德, 等. 改良电抽搐治疗对重度抑郁患者血清脑源性神经营养因子的影响 [J]. 中国心理卫生杂志, 2008, 22(2): 98-104.

[10] 徐佳, 李越. 改良电抽搐与抗抑郁剂对抑郁症治疗的比较 [J]. 临床精神医学杂志, 2010, 20(2): 113-114.

[11] 武佰玲, 刘萍. 中草药抗抑郁作用的研究进展 [J]. 中国医院用药评价与分析, 2011, 11 (7): 581-585.

[12] 裘涛, 陈眉, 陶水良, 等. 乌灵菌粉对脑卒中后抑郁大鼠海马区单胺类神经递质及行为学改变的影响 [J]. 中国新药杂志, 2007, 16(11): 857-860．

[13] 罗仁瀚, 徐凯, 黄云声. 针刺治疗抑郁症临床观察[J]. 上海针灸杂志, 2009, 28(2): 69-71.

[14] 魏波, 徐伊. 针刺治疗抑郁症72例临床观察 [J]. 暨南大学学报(医学版), 2013, 34(6): 664-666.

[15] 黄昕, 石朗, 孙晶, 等. 针刺对抑郁症的临床疗效及作用机制 [J]. 中医药信息，2013, 30 (4): 68-69.

[16] 姜磊, 赵军. 针灸结合药物治疗脑卒中后抑郁的临床研究 [J]. 针灸临床杂志, 2011, 27(11): 15-17.

[17] 刘志良, 老锦雄, 潘清洁. 背俞穴温针灸干预卒中后抑郁的临床观察 [J]. 上海针灸杂志, 2013, 32(4): 255-257.

[18] 雷俊. 针灸治疗帕金森病抑郁的临床观察 [J]. 求医问药(下半月), 2012, 10(4): 76.

[19] 隋汝华, 张磊, 隋汝波. 针灸治疗急性脑卒中后抑郁72例临床观察 [J].中国民族民间医药, 2009, 18(11): 94-95.

[20] 王绘, 唐云生.针灸联合心理疗法对初次胰岛素治疗的糖尿病伴抑郁焦虑症患者的临床研究 [J]. 长春中医药大学学报, 2012, 28(3): 408-409.

[21] 李俊玲, 牟凯.中西医结合治疗脑卒中后抑郁的疗效观察 [J].实用心脑肺血管病杂志, 2013, 21(5): 57- 58.

[22] 徐艳, 唐文君, 唐宇凤. 中西医结合治疗支气管哮喘伴抑郁80例临床分析 [J].实用中医药杂志, 2013, 29(12): 1014-1015.

[23] 国家药典委员会.中华人民共和国药典[M]. 一部. 北京: 中国医药科技出版社, 2010: 296-297.

[24] 吴禹, 胡长林. 银杏叶提取物对大鼠学习记忆能力的影响 [J]. 现代预防医学, 2008, 35(13): 2585-2586.

[25] 董继承, 王殉, 缪竞诚. 抑郁症与免疫功能的相关性 [J].青岛大学医学院学报, 2011, 47(1): 91-94.

[26] 秦晓松, 金魁和, 丁宝坤. 银杏叶提取物联合盐酸文拉法辛对抑郁大鼠海马nNOS 蛋白表达及NO 水平的影响 [J].中国心理卫生杂志, 2003, 17(12): 828-831.

[27] 秦晓松, 金魁和. 银杏叶提取物联合盐酸文拉法辛对抑郁大鼠海马BNDF表达及行为学改变的影响 [J]. 中国神经精神疾病杂志, 2003, 29(3): 187-189.

[28] Qin Xiao-song, Jin Kui-he, Ding Bao-kun, et al. Effects of extract of Ginkgo biloba with venlafaxine on brain injury in a rat model of depression [J]. Chin Med J (Engl), 2005, 118(5):391-397.

[29] George S Alexopoulos, Barnett S Meyers, Robert C Young, et al. Vascul ardepression hypothesis [J]. Arch Gen Psychiatry, 1997, 54(10): 915-922.

[30] Krishnan K R, Hays J C, Blazer D G, et al. MRI-defined vasculardepression [J]. Am J Psychiatry, 1997, 154(4): 497-501.

[31] 罗向东, 吴景芬, 周波, 等．帕罗西汀联合银杏叶片治疗血管性抑郁的疗效研究[J]．西部医学, 2011, 23(9): 1644-1646.

[32] 罗向东, 吴景芬, 周波, 等．帕罗西汀联合银杏叶片治疗血管性抑郁对血清BDNF 的影响及疗效观察 [J]．四川医学, 2012, 33 (1): 4-6.

[33] 韩伯军, 朱祖福, 孔玉. 曲唑酮联合银杏叶提取物治疗血管性抑郁症的疗效对照分析 [J]．四川精神卫生, 2005, 18(1): 20-22.

[34] 陈斌华, 齐若兵, 苏雪倩, 等. 银杏叶制剂合并西酞普兰治疗血管性抑郁的对照研究 [J]．浙江中医药大学学报, 2011, 35 (4): 513-515.

[35] 龚飞中, 曾骥, 谭伟．银杏叶提取物合并氢溴酸西酞普兰治疗抑郁症的临床研究 [J]．四川医学, 2010, 31 (10): 1482-1484.

[36] 苏祖禄, 苏海, 张毅, 等. 银杏叶提取物注射液对老年缺血性脑卒中患者血流动力学效应的影响及预后评价 [J]．中国老年学杂志, 2012, 32(23): 5130-5132.

[37] 李书超, 罗红艳. 帕罗西汀联合银杏叶片及早期心理干预治疗卒中后抑郁/焦虑的疗效观察 [J]．中原医刊, 2006, 33(24): 48-49.

[38] 徐海虹, 叶子. 加味小柴胡汤合银杏叶片治疗脑卒中后抑郁症46例 [J]．实用中医内科杂志, 2006, 20(3): 294-295.

[39] 陈伟, 吴杲. 盐酸氟西汀联合银杏叶片治疗脑卒中后抑郁障碍疗效观察[J]．现代中西医结合杂志, 2006, 15(2): 183-184.

[40] 窦林英. 西肽普兰联合银杏叶提取物在老年冠心病人合并抑郁中的应用[J]．中国实用医药, 2013,8(26): 41-42.

[41] 马永盛. 银杏叶提取物联合 SSRIs对老年冠心病患者合并抑郁的疗效分析[J]．中国实用医药, 2012, 7(19): 49-50.

[42] 袁佳, 张兰, 刘干, 等. 银杏叶片联合人际心理干预治疗冠心病伴抑郁症的临床研究 [J]．中国新药与临床杂志, 2011, 30(12): 920-924.

[43] 王敏, 王宏宇. 老年抑郁症与血管疾病[J]．中国民康医学杂志, 2006, 18(2): 136-1411.

[44] 肖斐. 银杏叶提取物联合SSRIs 治疗晚发性抑郁的疗效研究[D].大连: 大连医科大学, 2007.

[45] 马永盛, 马洪胜．银杏叶提取物联合西肽普兰治疗老年抑郁症的研究[J]．中国实用医药, 2010, 5(30) : 51-52.

[46] Hiroyuki Sakakibara, Kaori Ishida, Oliver Grundmann, et al. Antidepressant effect of extracts from Ginkgo biloba leaves in behavioral models [J]. Biol Pharm Bull, 2006, 29(8): 1767-1770.

[47] 陈炯, 王佩蓉, 陈文松, 等．银杏叶提取物合舍曲林治疗抑郁症临床观察[J]．浙江中西医结合杂志, 2005, 15(12): 756-757.

[48] 郭克锋, 郭珊, 闫凯麟．帕罗西汀加银杏叶提取物治疗抑郁症的疗效 [J]．中国行为医学科学, 2006, 15(8): 704-706.

[49] 李明华, 刘颖慧, 解蔚, 等. 吉舒配合银杏叶制剂治疗对哮喘患者心理改变的影响[C]. 第四届中国中西医结合变态反应学术会议论文汇编，2009.

[50] 杨世春, 赖坤平. 盐酸氟西汀联合银杏叶软胶囊治疗伴发抑郁症的慢性乙型肝炎疗效观察[J]．亚太传统医药, 2010, 6(6): 68-69.

[51] 赵妍, 包怡敏, 夏趁意, 等. 银杏酮酯对抑郁模型大鼠行为学及血清皮质酮的影响[J]．上海中医药杂志, 2013, 47(9): 70-73.

[52] Patricia Rojas, Norma Serrano-Garcia, Omar N Medina-Campos, et al. Antidepressant-like effect of a Ginkgo biloba extract (EGb761) in the mouse forced swimming test: role of oxidative stress[J]．Neurochem Int, 2011, 59(5): 628-636.

[53] Satyan S Kalkunte, Ajay P Singh, Fabio C Chaves, et al. Antidepressant and antistress activity of GC-MS characterized lipophilic extracts of Ginkgo biloba leaves [J]. Phytother Res, 2007, 21(11): 1061-1065.

Ginkgo BilobaLeaves and Depression

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

[1]	XIE bin, HUANG Zhi-yuan, LIN Duo-duo, YANG Fu-long, XIE Yi-bin.Effect of Acupuncture Combined with Medicine on Depressive Symptoms of Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 5-8.
[2]	MO Cui-ying, LUO Guo-ping.Influence of Nimergoline Combined with Trasylin and Psychotherapy for Depression in Patients with Post-stroke Depression[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(2): 7-10.
[3]	FU Zhi-jiang1，GAO Yun2，ZHANG Wei3，LIU Zong-chao1，4，ZHANG Hua-wen4，LIU Shi-gui1，HUANG Chen-yi1，GAO Yin5，GAO Hai-ming1.Effects and Mechanisms of Depression on Bone Fracture Healing in Rats[J]. Acta Neuropharmacologica, 2018, 8(6): 1-8.
[4]	FU Zhi-jiang1，LIU Yong1，GAO Yin1，ZHANG Wei2，GAO Yun2，LIU Zong-chao1*.Effects and Mechanisms of Depression on Bone Fracture Healing in Rats[J]. Acta Neuropharmacologica, 2018, 8(4): 5-6.
[5]	LIANG Jian-hui1,2*, LIANG hui2, CHENG tao1, LIU Xiao-yan1, Simon M.Y.Lee3, TANG Ben-qin3, WANG Xiu-fen3, CHEN Feng4,Andrew J. Lawrence4.Comorbidity of Anxiety and Depression Induced by Liang’s Contextual-Stress Box in Mice[J]. Acta Neuropharmacologica, 2018, 8(4): 44-45.
[6]	ZAN Gui-ying，SUN Xiang，LI Qing-lin，LIU Jing-gen.Research Progress of the Role and Underlying Mechanism of Dynorphin/κ Opioid Receptor in the Development of Depression[J]. Acta Neuropharmacologica, 2018, 8(1): 54-64.
[7]	LIANG Hui，CHENG Tao，LIANG Jian-hui.Progress in the Comorbidity of Depression and Anxiety[J]. Acta Neuropharmacologica, 2017, 7(6): 30-35.
[8]	ZHANG Kuo，YANG Jing-yu，WU Chun-fu.Progress on Pathophysiology and Animal Models of Depression[J]. Acta Neuropharmacologica, 2017, 7(4): 8-16.
[9]	REN Qian,WANG Zhen-zhen,CHEN Nai-hong.Regulation of Neuroplasticity by MicroRNA in Depression Disorder[J]. Acta Neuropharmacologica, 2017, 7(3): 12-20.
[10]	DU Guan-tao， LIN Jing-ran,LIU Guang-jun， HONG Hao.Research Progress on the Correlation Between Alzheimer’s Disease and Depression[J]. Acta Neuropharmacologica, 2016, 6(6): 40-44.
[11]	CAO Li-hua，BAI Ming，FANG Xiao-yan，WANG Can，MIAO Ming-san.Analysis of Animal Models of Depression Based on Clinical Symptoms[J]. Acta Neuropharmacologica, 2016, 6(4): 19-23.
[12]	ZHANG Xiao-ling，WANG Zhen-zhen，WEN Lu，SHAO Qian-hang，CHEN Nai-hong.The Relationship between Cytokines and Depression[J]. Acta Neuropharmacologica, 2016, 6(4): 31-36.
[13]	WANG Sha-sha，ZHANG Zhao，ZHANG Mei-jin，HU Jin-feng，CHEN Nai-hong.Advances of Nrf 2/ARE Signaling Pathway in the Major Depression Disorder[J]. Acta Neuropharmacologica, 2016, 6(3): 32-37.
[14]	HE Hai-ran，XUE Zhan-xia.Research Progress in the Pathogenesis of Depression[J]. Acta Neuropharmacologica, 2016, 6(2): 20-25.
[15]	JIANG Xiang-yun，SHANG Chao，LI Lei，SUN Shu-zheng，LI Yun-feng，WANG Heng-lin.Allopregnanolone as a New Therapeutic Target for Depression and Anxiety[J]. Acta Neuropharmacologica, 2016, 6(2): 26-30.